Item 5. Other Information
ITEM
5. OTHER INFORMATION
None.
42
ITEM
6. EXHIBITS
Incorporated
by Reference
Exhibit
Number
Exhibit
Description
Form
Exhibit
Filing
Date/Period End Date
1.1*
First Amendment dated September 26, 2023 to the Credit Agreement among Avenue Venture Opportunities Fund II, L.P., Avenue Venture Opportunities Fund, L.P. and LifeMD, Inc.
10.1 #
Second Amendment dated July 11, 2023 to the Employment Agreement between Marc Benathen and LifeMD, Inc.
8-K
10.3
7/14/2023
10.2 #
Restricted Stock Award Agreement dated July 11, 2023 between Marc Benathen and LifeMD, Inc
8-K
10.4
7/14/2023
10.3 #*
Amended and Restated First Amendment dated July 26, 2023 to the Amended and Restated Employment Agreement between Nicholas Alvarez and LifeMD, Inc.
10.4#*
Restricted Stock Award Agreement dated July 26, 2023 between Nicholas Alvarez and LifeMD, Inc
31.1*
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.
31.2*
Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.
32.1**
Section 1350 Certification of Chief Executive Officer.
32.2**
Section 1350 Certification of Chief Financial Officer.
101.INS*
Inline XBRL Instance Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase
Document
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase
Document
101.LAB*
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase
Document
104*
Cover Page Interactive Data File (formatted as Inline
XBRL and contained in Exhibit 101.INS)
#
Indicates management contract or compensatory plan, contract or arrangement.
*
Filed herewith.
**
Furnished herewith
43
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
LIFEMD,
INC.
By:
/s/
Justin Schreiber
Justin Schreiber
Chief Executive Officer and Chairman of the Board of
Directors
Date:
November 8, 2023
By:
/s/ Marc
Benathen
Marc Benathen
Chief Financial Officer
Date:
November 8, 2023
By:
/s/ Maria
Stan
Maria Stan
Principal Accounting Officer
Date:
November 8, 2023
44
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.